Correvio Pharma Corp. Deferred Revenue
Correvio Pharma Corp. had Deferred Revenue of $0 as of 2018-12-31, per its 40-F filed 2019-03-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2019-03-13
- 2018-12-31: Deferred Revenue, Current $0.00.
- 2017-12-31: Deferred Revenue, Current $207.00K.
- 2016-12-31: Deferred Revenue, Current $182.00K.
- 2015-12-31: Deferred Revenue, Current $188.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2018-12-31 | $0.00 40-F · filed 2019-03-13 |
| 2017-12-31 | $207.00K 40-F · filed 2019-03-13 |
| 2016-12-31 | $182.00K 20-F · filed 2018-04-30 |
| 2015-12-31 | $188.00K 40-F · filed 2017-03-29 |
| 2014-12-31 | $0.00 40-F · filed 2016-03-29 |